HSF1 and cancer: HSF1 has since also been recognized for its pro-oncogenic properties, contributing to cancer initiation, progression, and chemoresistance (Kijima et al., 2019; Lee et al., 2021; Cyran and Zhitkovich, 2022; Gumilar et al., 2023).